Workflow
可转换公司债券
icon
Search documents
旗滨集团: 旗滨集团关于公开发行可转换公司债券2025年跟踪评级结果的公告
Zheng Quan Zhi Xing· 2025-06-20 11:29
Core Viewpoint - The company, Zhuzhou Qibin Group Co., Ltd., has maintained its credit ratings for both the company and its convertible bonds, indicating stable financial health and outlook [1][2]. Group 1: Credit Ratings - Previous credit rating for the company was "AA+" with a stable outlook, and the bond "Qibin Convertible Bond" had a credit rating of "AA" [1]. - The current credit rating remains "AA+" for the company and "AA+" for the bond, showing no change from the previous assessment [2]. - The tracking rating report was issued by New Century Rating on June 20, 2025, after a comprehensive analysis of the company's operational status and industry conditions [2]. Group 2: Regulatory Compliance - The company conducted the rating in accordance with regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [1][2]. - The detailed tracking rating report is available on the Shanghai Stock Exchange website for investors to review [2].
XD兴业银: 兴业银行股份有限公司公开发行A股可转换公司债券受托管理事务报告(2024年度)
Zheng Quan Zhi Xing· 2025-06-20 11:00
Core Viewpoint - The report outlines the issuance and management of the convertible bonds by Industrial Bank Co., Ltd., detailing the financial performance, bond terms, and the use of raised funds for business development and capital supplementation [1][2][3]. Section 1: Bond Issuance Details - The issuance of A-share convertible bonds was approved by the board on May 21, 2021, and by the shareholders on June 11, 2021, with a maximum issuance limit of 50 billion RMB [2][3]. - On December 27, 2021, the bank issued 50 million convertible bonds at a face value of 100 RMB each, raising a total of 50 billion RMB, with a net amount of approximately 49.92 billion RMB after deducting issuance costs [3][4]. Section 2: Key Terms of the Bonds - The bonds have a term of 6 years, from December 27, 2021, to December 26, 2027, with a face value of 100 RMB [4]. - The coupon rates are structured to increase over the years, starting at 0.2% in the first year and reaching 3.0% in the sixth year [4][5]. Section 3: Financial Performance - For the year 2024, the bank reported total operating income of 212.23 billion RMB, a slight increase of 0.66% from 2023 [14]. - The total profit reached 87.12 billion RMB, reflecting a growth of 3.31% compared to the previous year [14]. - The net profit attributable to shareholders was 77.21 billion RMB, showing a marginal increase of 0.12% from 2023 [14]. Section 4: Use of Raised Funds - The funds raised from the bond issuance have been fully utilized to support the bank's business development and will be used to supplement core tier one capital after bondholders convert their bonds into shares [16]. Section 5: Bondholder Rights and Management - The bondholders have the right to redeem their bonds at 109% of the face value plus the last interest payment if certain conditions are met, such as the stock price exceeding 130% of the conversion price for a specified period [11][12]. - The bond trustee, CITIC Securities, has been monitoring the bank's financial health and compliance with the bond management agreement [12][18]. Section 6: Adjustments to Conversion Price - The initial conversion price was set at 25.51 RMB per share, which has been adjusted down to 22.25 RMB due to dividend distributions [19][20].
高测股份: 关于“高测转债”跟踪信用评级结果的公告
Zheng Quan Zhi Xing· 2025-06-20 10:50
Group 1 - The core viewpoint of the announcement is that Qingdao Gaomei Technology Co., Ltd. maintains its credit rating of A+ for both the company and its convertible bonds, with a stable outlook [1][2] - The credit rating was conducted by China Chengxin International Credit Rating Co., Ltd., which assessed the company's operational status and related industry [1] - The previous credit rating was also A+, and the latest tracking rating report was issued on June 20, 2025 [1] Group 2 - The tracking rating report has been disclosed on the Shanghai Stock Exchange website [2]
闻泰科技: 华泰联合证券有限责任公司关于闻泰科技股份有限公司公开发行可转换公司债券受托管理事务报告(2024年度)
Zheng Quan Zhi Xing· 2025-06-20 10:50
Overview of the Convertible Bond Issuance - Wintai Technology Co., Ltd. has been approved to publicly issue convertible bonds not exceeding 8.6 billion yuan [1][2] - The bonds, referred to as "Wintai Convertible Bonds," have a maturity of six years and an annual interest rate of 1.80% for the first five years and 2.00% for the sixth year [1][2] Key Terms of the Convertible Bonds - The bonds will pay interest annually, with the first payment starting on July 28, 2021 [1] - The redemption price at maturity will be 108 yuan per bond, including the last interest payment [2] - The company has the right to adjust the conversion price downwards if the stock price falls below 85% of the conversion price for at least 15 out of 30 consecutive trading days [1][2] Financial Performance - In 2024, the company reported a net profit attributable to shareholders of -2.833 billion yuan, a significant decline from a profit of 118 million yuan in 2023 [7][8] - The total revenue for 2024 was approximately 7.36 billion yuan, reflecting a year-on-year increase of 20.23% [8] - The company's total assets at the end of 2024 were approximately 7.50 billion yuan, a decrease of 2.59% compared to the previous year [8] Use of Proceeds from the Convertible Bonds - The company plans to change the use of raised funds, reallocating remaining funds to supplement working capital permanently due to uncertainties in project benefits [9][10] - As of the end of the reporting period, 587.05 million yuan of the raised funds had been utilized, with 50% of the funds being redirected [9][10] Company Background - Wintai Technology operates in the semiconductor and product integration sectors, utilizing an Integrated Device Manufacturer (IDM) model [7] - The company is listed on the Shanghai Stock Exchange under the stock code 600745 and the convertible bond code 110081 [6]
宏川智慧: 关于“宏川转债”转股价格调整的公告
Zheng Quan Zhi Xing· 2025-06-20 10:49
Group 1 - The company announced an adjustment to the conversion price of its convertible bonds from 18.76 CNY/share to 18.56 CNY/share, effective from June 24, 2025 [1][2][3] - The adjustment is due to a cash dividend distribution of 2.00 CNY for every 10 shares, which was approved at the annual shareholders' meeting on May 20, 2025 [2][3] - The calculation for the new conversion price is based on the formula P=Po-D, where Po is the previous conversion price and D is the cash dividend [3] Group 2 - The company will not issue bonus shares or increase capital from reserves during this dividend distribution [2] - The adjustment to the conversion price will be communicated through official announcements in accordance with regulatory requirements [2] - The company emphasizes the protection of the rights and interests of convertible bondholders during any changes in share structure or equity [2]
美诺华: 宁波美诺华药业股份有限公司关于权益分派引起的“美诺转债”转股价格调整的公告
Zheng Quan Zhi Xing· 2025-06-20 10:45
证券代码:603538 证券简称:美诺华 公告编号:2025-078 转债代码:113618 转债简称:美诺转债 宁波美诺华药业股份有限公司 关于权益分派引起的"美诺转债"转股价格调整的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 经中国证券监督管理委员会《关于核准宁波美诺华药业股份有限公司公开发 行可转换公司债券的批复》(证监许可20202377 号)核准,2021 年 1 月 14 日, 宁波美诺华药业股份有限公司(以下简称"公司")公开发行 52,000 万元可转换 公司债券,共发行 520 万张,每张面值 100 元,期限 6 年。2021 年 2 月 4 日起, 上述可转换公司债券在上海证券交易所挂牌交易,转债简称"美诺转债",转债代 码"113618"。 "美诺转债"存续的起止日期为 2021 年 1 月 14 日至 2027 年 1 月 13 日,转 股期起止日期为 2021 年 7 月 20 日至 2027 年 1 月 13 日,初始转股价格为 37.47 元/股。 ? 证券停复牌情况: ...
江苏华辰: 江苏华辰第三届监事会第十六次会议决议公告
Zheng Quan Zhi Xing· 2025-06-20 10:36
Meeting Overview - The 16th meeting of the third Supervisory Board of Jiangsu Huachen Transformer Co., Ltd. was held on a specified date, with all three supervisors present, ensuring compliance with relevant laws and regulations [1] Convertible Bond Issuance - The Supervisory Board approved the proposal for the issuance of convertible bonds, with a total issuance scale of RMB 460 million, equivalent to 4.6 million bonds at a face value of RMB 100 each [2] - The bonds will have a term of 6 years, from June 20, 2025, to June 19, 2031, with a tiered interest rate starting at 0.20% in the first year and increasing to 2.50% in the sixth year [2] - The initial conversion price is set at RMB 23.53 per share, based on the average trading price of the company's stock over the previous 20 trading days [3][4] Credit Rating - The company has engaged a credit rating agency, with the long-term credit rating for the company set at A+ and the convertible bonds also rated A+ [3] Conversion and Redemption Terms - The conversion period for the bonds will start six months after issuance and last until the maturity date [2] - The company has outlined conditions for adjusting the conversion price, including adjustments for stock dividends and other corporate actions [4][5] - Upon maturity, the company will redeem the bonds at 114% of the face value, including the last interest payment [7] Shareholder Rights - Existing shareholders will have priority in subscribing to the convertible bonds based on their shareholding as of the record date, with a specific allocation ratio [12][13] - The bonds will not be secured, and the company will manage the funds raised through a dedicated account [15] Governance Changes - The company plans to abolish the Supervisory Board and amend its Articles of Association to enhance governance and compliance with legal requirements [15][16]
灵康药业: 关于“灵康转债”2025年跟踪评级结果的公告
Zheng Quan Zhi Xing· 2025-06-20 10:13
Core Viewpoint - The company, Lingkang Pharmaceutical Group Co., Ltd., has maintained its credit rating for both the company and its convertible bonds, indicating stable financial health and outlook [1][2]. Summary by Relevant Sections Company Credit Rating - The company's credit rating remains at "A-" with a stable outlook, consistent with the previous rating [1][2]. - The last rating was conducted by Dongfang Jincheng International Credit Assessment Co., Ltd. on June 18, 2024 [1]. Convertible Bond Rating - The credit rating for the "Lingkang Convertible Bonds" is also maintained at "A-" with a stable outlook, showing no change from the previous assessment [2].
灵康药业: 灵康药业集团股份有限公司公开发行A股可转换公司债券受托管理事务报告(2024年度)
Zheng Quan Zhi Xing· 2025-06-20 10:13
灵康药业集团股份有限公司 公开发行 A 股可转换公司债券 受托管理事务报告 (2024 年度) 债券受托管理人 二〇二五年六月 重要声明 本报告依据《公司债券发行与交易管理办法》(以下简称"《管理办法》") 《灵康药业集团股份有限公司公开发行 A 股可转换公司债券受托管理协议》 (以 下简称"《受托管理协议》")《灵康药业集团股份有限公司公开发行 A 股可 转换公司债券募集说明书》(以下简称"《募集说明书》")《灵康药业集团股 份有限公司 2024 年年度报告》等相关公开信息披露文件、第三方中介机构出具 的专业意见等,由本期债券受托管理人中信证券股份有限公司(以下简称"中信 证券")编制。中信证券对本报告中所包含的从上述文件中引述内容和信息未进 行独立验证,也不就该等引述内容和信息的真实性、准确性和完整性做出任何保 证或承担任何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见,投资者应对相关 事宜做出独立判断,而不应将本报告中的任何内容据以作为中信证券所作的承诺 或声明。在任何情况下,投资者依据本报告所进行的任何作为或不作为,中信证 券不承担任何责任。 目 录 第一节 本期债券情况 一、核准文件及核 ...
大中矿业: 关于实施权益分派期间“大中转债”暂停转股的公告
Zheng Quan Zhi Xing· 2025-06-20 09:45
Core Viewpoint - Dazhong Mining Co., Ltd. will implement the 2024 annual equity distribution soon, leading to a temporary suspension of the conversion of its convertible bonds due to the existence of shares in the company's repurchase account [1][2]. Group 1: Equity Distribution and Convertible Bonds - The company is set to implement an equity distribution plan, which necessitates the suspension of the conversion of its convertible bonds, referred to as "Dazhong Convertible Bonds" [1]. - The suspension of conversion is in accordance with the regulations outlined in the Shenzhen Stock Exchange's self-regulatory guidelines, specifically regarding the issuance of convertible bonds during equity distribution [1]. - The company will resume the conversion of the convertible bonds after the equity distribution is completed and will notify bondholders accordingly [2]. Group 2: Adjustment of Conversion Price - The adjustment of the conversion price for the convertible bonds will occur in the event of stock dividends, capital increases, new share issuances, or cash dividends, following specific formulas [3]. - The formulas for adjusting the conversion price are detailed, including variables such as the previous conversion price, stock dividend rate, and cash dividend amount [3]. - The company will announce any adjustments to the conversion price and the relevant dates through designated media, ensuring transparency for bondholders [4].